mucoderm® is an acellular collagen matrix that offers a safe alternative to autologous soft tissue transplants in a diverse range of soft tissue grafting indications. mucoderm® is derived from porcine dermis that undergoes a multi-step purification process, which removes all non-collagenous proteins and cells as well as potential immunogens, bacteria and viruses. The processing results in a three-dimensional, stable matrix, which consists of collagen type I and III with a natural collagen structure that resembles the human connective tissue 1, 2. After implantation mucoderm® is continuously remodeled into patients own soft tissue.
mucoderm® is an acellular collagen matrix that offers a safe alternative to autologous soft tissue transplants in a diverse range of soft tissue grafting indications. mucoderm® is derived from porcine dermis that undergoes a multi-step purification process, which removes all non-collagenous proteins and cells as well as potential immunogens, bacteria and viruses. The processing results in a three-dimensional, stable matrix, which consists of collagen type I and III with a natural collagen structure that resembles the human connective tissue. After implantation mucoderm® is continuously remodeled into patients own soft tissue.
ALTERNATIVE TO AUTOLOGOUS SOFT TISSUE
RAPID REVASCULARIZATION
COMPLETE REMODELLING INTO PATIENT’S OWN TISSUE
×
SCAFFOLD FOR INGROWING CELLS AND VESSELS
mucoderm® shows a high porosity and native collagen structure making it an excellent scaffold for ingrowing blood vessels and cells, thus supporting a fast revascularization and tissue integration 3. Attracted by the signals of activated migrating and proliferating endothelial cells, blood vessels from the surrounding tissue will grow into the matrix. At the same time, fibroblasts adhere and spread onto the matrix. The simultaneous degradation of the matrix and the collagen production of adhering fibroblasts leads to a complete substitution of mucoderm® by the newly formed host tissue within about 6-9 months
×
mucoderm®
Properties & Advantages
• Rapid revascularization and tissue integration
• Soft tissue regeneration/augmentation without palatal autograft harvesting
• Complete remodelling into patient’s own tissue in ~6-9 months
• Can be easily applied and fixed by sutures
• Can be cut into procedure-specific shape
×
mucoderm®
Indications
mucoderm® can be applied as an alternative to autologous soft tissue transplants such as connective tissue graft (CTG) and free gingival graft (FGG) in various indications in periodontology and implantology. The use of mucoderm® is of particular advantage in situations where autologous transplants cannot be harvested in sufficient amount or quality (e.g. in thin biotype, shallow palate or covering of multiple recessions) or if patients are afraid of and do not agree with a tissue harvesting.
IMPLANTOLOGY, PERIODONTOLOGY AND ORAL AND CMF SURGERY
• Soft tissue grafting in combination with GBR/GTR
• Broadening of attached gingiva (instead of FGG)
• Treatment of gingival recessions
• Thickening of periimplant soft tissue
• Closure of extraction sockets (socket seal technique)
• Oral wound coverage after transplant harvesting or tumor surgery
×
Privacy Policy
EFFECTIVE DATE: DECEMBER 10, 2024
SPECIFIC FACTS
Highest Safety
The particular, certified multi-stage cleaning process of mucoderm® effectively removes all non-collagenous proteins and cells as well as potential immunogens, bacteria and viruses. Hence, mucoderm® is an absolutely safe and pure collagen type I and III matrix. mucoderm® is a medical device regulated according to EC-Guidelines. Manufacturing of mucoderm® is subject to a quality control system based on international standards (e.g. EN ISO 13485), and is regularly audited by the notified body and authorities.
Native Collagen Structure
mucoderm® is a native collagen matrix, meaning that the natural properties of the original tissue (dermis) are preserved during the production process. This is the basis for its superior handling properties such as tear resistance and dimensional stability. Preservation of the natural structure is also the reason that mucoderm® structure strongly resembles the architecture of the human dermis1, making the matrix a suitable alternative to autologous gingival transplants.
Tissue Integration, Revascularization and Degradation
mucoderm® is characterized by a porous collagen structure, visualized by the innovative synchrotron-based X-ray tomography: Synchrotron-based X-ray tomographic microscopy for visualization of three-dimensional collagen matrices.
Synchrotron-based x-ray image showing the porous structure of mucoderm®
This unique structure makes mucoderm® an ideal scaffold for ingrowth of blood vessels and cells and promotes fast tissue integration and revascularization. Tissue integration and degradation were analyzed in an animal (rat model) study of Prof. Daniel Rothamel4. After only two weeks, mucoderm® shows an extensive ingrowth of blood vessels as well as an inflammation-free healing with superficial cell invasion. In the following four to eight weeks, a continuous degradation with increasing homogeneous cell distribution can be observed. After eight weeks, still 20% of the original matrix volume is available as a scaffold for the formation and reorganization of connective tissue. After twelve weeks, mucoderm® is almost completely replaced by newly formed connective tissue.
Combination of mucoderm® with Enamel Matrix Proteins
mucoderm® supports the maintenance and thickening of gingival tissue, which can be particularly advantageous in thin biotypes. The additional application of Straumann® Emdogain® during recession coverage with mucoderm® can:
• improve the qualitative attachment;
• stimulate angiogenesis and thus improve the revascularization and integration of mucoderm®;
• increase the quantity of keratinized tissue, which can be beneficial in case of lack or absence of keratinized gingiva 14.
Contact Us
If you have any questions about this Privacy Policy, please contact us at office@megagen.co.uk
HANDLING TIPS
HYDRATION
mucoderm® should always be applied after rehydration (in sterile saline, defect blood, or platelet concentrates). Rehydration should be performed for five to 20 minutes, depending on the technique used and the desired flexibility of the matrix. The flexibility of the mucoderm® increases with rehydration time. The rehydration protocol and its influence on the biomechanical properties of mucoderm® were analyzed in a study of Prof Dr. Adrian Kasaj.
TRIMMING
Size and shape of the matrix should be adapted to the size of the defect. After rehydration, mucoderm® can be easily trimmed to the desired size with a scalpel or scissors. Cutting or rounding the edges can prevent the perforation of the gingival tissue during the flap closure. For the coverage of multiple recessions, the surface of mucoderm® can be extended by cutting the matrix on alternating sides (mesh-graft technique) and pulling it.
IMMOBILIZATION/FIXATION
Following application, mucoderm® should always be stabilized to avoid micro movements and ensure undisturbed revitalization, e.g. ingrowth of vessels and cells. When preparing a split flap, mucoderm® should be sutured to the intact periosteum to ensure close contact between the matrix and the periosteal wound bed. Single button or cross sutures may be used; the use of resorbable sutures is recommended. Both sides of the matrix are comparable, since mucoderm® shows a homogenous structure.
EXPOSURE
mucoderm® can be left exposed for open healing in situations in which revitalization from the surrounding or underlying wound bed is ensured. Always avoid exposure of mucoderm® when used in recession coverage. A close flap is also recommended when simultaneously applied with bone grafting materials. Open healing is feasible in the case of a vestibuloplasty, if mucoderm® is sutured to the periosteum. In this case mucoderm® should be closely fixed to the periosteum. This facilitates an increase in the width of the attached gingiva but not in the thickening of the tissue. Open healing is also possible if only minor parts of the matrix are exposed, and revascularization is ensured by the surrounding margins of the flap or by the underlying periosteum. Please note that the degradation time depends on the extent of the exposure and will be faster due to bacterial decontamination and resorption.
FLAP PREPARATION
mucoderm® can be used in combination with all mucogingival surgical techniques, including coronally advanced flap and tunnel techniques. Notably, the classical coronally advanced flap or the modified coronally advanced flap ensure a good view on the prepared donor bed and facilitate the coronal repositioning of the flap over the matrix. Advanced flaps need to be sufficiently mobilized to avoid tension of the soft tissue. A proper vascular supply from the prepared flap is critical to achieve an appropriate revascularization of the mucoderm® matrix. In particular, split flaps must be sufficiently thick to ensure revitalization of the matrix and the integration into the patient’s own connective tissue. When applying mucoderm® for recession coverage, special attention must be paid to achieve sufficient flap mobilization and tension-free closure.
Straumann® Emdogain®/ Combination of mucoderm® with Straumann® Emdogain® treatment
Straumann® Emdogain® is an easy-to-apply gel containing enamel matrix derivative originating from non-erupted porcine tooth buds. As a component of embryonic tissues it is designed to promote predictable regeneration of hard and soft tissue due to periodontal disease or trauma. Gingival recessions may be treated using mucoderm® and Straumann® Emdogain® together in a single approach. Always make sure that Straumann® Emdogain® is applied all over the root surfaces before the mucoderm® matrix is placed over the roots.
×
OUR BOTISS PRODUCTS
01 — 07
NOVAMag® membrane
Resorbable Magnesium Membrane
Jason® membrane
Native Pericardium GRB/GTR Membrane
maxgraft® granules
Processed Human Allograft
maxgraft® blocks
Processed Human Allograft
maxgraft® cortico
Bone augmentation with the shell technique
maxgraft® bonebuilder
Customized Allogenic bone block
NOVAMag® fixation screw
Resorbable magnesium screws
mucoderm®
Acellular dermal collagen matrix
collafleece®
Resorbable collagen for wound management
collacone®
High-Density PTFE Barrier Membrane
Meet with Your Local Representative
Be the first to know about our discount offers, events and giveaways.
THE FUTURE IS HERE
Join Megagen Community
Discover the latest in dental technology.
Join our community for exclusive offers and events.